150 related articles for article (PubMed ID: 12659684)
1. Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398.
Xu XC; Shappell SB; Liang Z; Song S; Menter D; Subbarayan V; Iyengar S; Tang DG; Lippman SM
Neoplasia; 2003; 5(2):121-7. PubMed ID: 12659684
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression.
Shureiqi I; Xu X; Chen D; Lotan R; Morris JS; Fischer SM; Lippman SM
Cancer Res; 2001 Jun; 61(12):4879-84. PubMed ID: 11406566
[TBL] [Abstract][Full Text] [Related]
3. 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.
Shureiqi I; Chen D; Lee JJ; Yang P; Newman RA; Brenner DE; Lotan R; Fischer SM; Lippman SM
J Natl Cancer Inst; 2000 Jul; 92(14):1136-42. PubMed ID: 10904086
[TBL] [Abstract][Full Text] [Related]
4. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
Shureiqi I; Chen D; Lotan R; Yang P; Newman RA; Fischer SM; Lippman SM
Cancer Res; 2000 Dec; 60(24):6846-50. PubMed ID: 11156377
[TBL] [Abstract][Full Text] [Related]
5. 15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer.
Wu J; Xia HH; Tu SP; Fan DM; Lin MC; Kung HF; Lam SK; Wong BC
Carcinogenesis; 2003 Feb; 24(2):243-7. PubMed ID: 12584173
[TBL] [Abstract][Full Text] [Related]
6. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention.
Hoque A; Lippman SM; Wu TT; Xu Y; Liang ZD; Swisher S; Zhang H; Cao L; Ajani JA; Xu XC
Carcinogenesis; 2005 Apr; 26(4):785-91. PubMed ID: 15661803
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells.
Li M; Wu X; Xu XC
Int J Cancer; 2001 Jul; 93(2):218-23. PubMed ID: 11410869
[TBL] [Abstract][Full Text] [Related]
9. NS-398 induces apoptosis in human esophageal cancer cells through inhibition of NF-kappaB downstream regulation of cyclooxygenase-2.
Liu JF; Zhu GJ; Jamieson GG; Wu TC; Zhu TN; Shan BE; Drew PA
Cancer Invest; 2009 Jan; 27(1):17-23. PubMed ID: 19160097
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer.
Heslin MJ; Hawkins A; Boedefeld W; Arnoletti JP; Frolov A; Soong R; Urist MM; Bland KI
Ann Surg; 2005 Jun; 241(6):941-6; discussion 946-7. PubMed ID: 15912043
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells.
Pan MR; Chuang LY; Hung WC
FEBS Lett; 2001 Nov; 508(3):365-8. PubMed ID: 11728453
[TBL] [Abstract][Full Text] [Related]
12. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
[TBL] [Abstract][Full Text] [Related]
14. Detection and subcellular localization of two 15S-lipoxygenases in human cornea.
Chang MS; Schneider C; Roberts RL; Shappell SB; Haselton FR; Boeglin WE; Brash AR
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):849-56. PubMed ID: 15728540
[TBL] [Abstract][Full Text] [Related]
15. The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma.
Zhi H; Zhang J; Hu G; Lu J; Wang X; Zhou C; Wu M; Liu Z
Int J Cancer; 2003 Sep; 106(3):327-33. PubMed ID: 12845669
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of 15-lipoxygenase 2 in human head and neck carcinomas.
Wang D; Chen S; Feng Y; Yang Q; Campbell BH; Tang X; Campbell WB
Tumour Biol; 2006; 27(5):261-73. PubMed ID: 16874012
[TBL] [Abstract][Full Text] [Related]
17. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
Baguma-Nibasheka M; Barclay C; Li AW; Geldenhuys L; Porter GA; Blay J; Casson AG; Murphy PR
Mol Carcinog; 2007 Dec; 46(12):971-80. PubMed ID: 17477358
[TBL] [Abstract][Full Text] [Related]
18. GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells.
Shureiqi I; Jiang W; Fischer SM; Xu X; Chen D; Lee JJ; Lotan R; Lippman SM
Cancer Res; 2002 Feb; 62(4):1178-83. PubMed ID: 11861401
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
